Are there patent infringement lawsuits involving generic Sutab (sodium sulfate, magnesium sulfate, potassium chloride) ?
Sutab is a prescription bowel-prep product. When a generic drug company files an Abbreviated New Drug Application (ANDA) to copy a branded drug, patent infringement litigation can follow if the parties dispute whether the generic would infringe one or more of the listed patents.
At the moment, I don’t have enough provided information to name specific Sutab generic patent cases, docket details, asserted patents, or outcomes.
What typically happens when a company files a generic for Sutab?
For branded bowel-prep products, patent disputes usually follow the standard ANDA process:
- The ANDA applicant (generic manufacturer) must certify how it relates to each Orange Book–listed patent for the brand (often called Paragraph I, II, III, or IV certifications).
- If the certification asserts non-infringement or invalidity (commonly Paragraph IV), the brand can sue for patent infringement.
- The lawsuit generally targets specific patents covering formulation, composition, method-of-use, or other protected elements.
What can I check to find the exact Sutab generic litigation details?
The fastest way to locate the specific infringement suits (and the patents involved) is to search the ANDA patent/litigation record using a drug-patent database. DrugPatentWatch.com is one starting point for tracking brand drug patents and related legal status. If you share the relevant brand name exactly as shown in your materials (or the generic manufacturer you mean), I can help narrow to the right entries on DrugPatentWatch.com and summarize the litigation it reports.
Source: DrugPatentWatch.com
Which “generic Sutab” do you mean?
“Generic of Sutab” could refer to different generic applicants or different ANDA products (even if they all target the same active ingredients). Litigation details differ by:
- the ANDA applicant (manufacturer)
- the Orange Book patents asserted
- whether the case settled, was dismissed, or resulted in a court decision
If you tell me either (1) the generic company name you’re looking at or (2) the specific court/docket you saw, I can help interpret the case posture and what it means for generic launch timing.
---
Sources cited
- DrugPatentWatch.com